{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T17:13:05Z","timestamp":1789146785849,"version":"build-2803163510"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272796"],"award-info":[{"award-number":["82272796"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82303969"],"award-info":[{"award-number":["82303969"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["8227252"],"award-info":[{"award-number":["8227252"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"publisher","award":["2024ZD0520202"],"award-info":[{"award-number":["2024ZD0520202"]}],"id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"publisher","award":["2024ZD0519700"],"award-info":[{"award-number":["2024ZD0519700"]}],"id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018904","name":"Beijing Xisike Clinical Oncology Research Foundation","doi-asserted-by":"publisher","award":["Y-2024AZ(EGFR)MS-0079"],"award-info":[{"award-number":["Y-2024AZ(EGFR)MS-0079"]}],"id":[{"id":"10.13039\/100018904","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.lungcan.2026.109566","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:34:58Z","timestamp":1786322098000},"page":"109566","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Genomic Profiling, Risk Stratification, and Post-Transformation Treatment Outcomes in Patients with Transformed Small-Cell Lung Cancer: A Multicenter Analysis"],"prefix":"10.1016","volume":"220","author":[{"given":"Ruolin","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ZhenXiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinxiang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangchuan","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianchun","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiachen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boyang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kailun","family":"Fei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixiao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5602-0487","authenticated-orcid":false,"given":"Jie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.lungcan.2026.109566_b0005","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1093\/annonc\/mdt205","article-title":"Mutation incidence and coincidence in non small-cell lung cancer: meta-analyses by ethnicity and histology (mutMap)","volume":"24","author":"Dearden","year":"2013","journal-title":"Ann Oncol."},{"issue":"1","key":"10.1016\/j.lungcan.2026.109566_b0010","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1056\/NEJMoa1913662","article-title":"Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC","volume":"382","author":"Ramalingam","year":"2020","journal-title":"N Engl J Med."},{"issue":"10","key":"10.1016\/j.lungcan.2026.109566_b0015","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1016\/j.jtho.2019.06.002","article-title":"Concurrent RB1 and TP53 Alterations Define aSubset of EGFR-Mutant Lung Cancers at risk forHistologic Transformation and Inferior Clinical Outcomes","volume":"14","author":"Offin","year":"2019","journal-title":"J Thorac Oncol."},{"issue":"1","key":"10.1016\/j.lungcan.2026.109566_b0020","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.pccm.2023.10.005","article-title":"Small cell lung cancer transformations from non-small cell lung cancer: Biological mechanism and clinical relevance","volume":"2","author":"Yang","year":"2024","journal-title":"Chin Med J Pulm Crit Care Med."},{"issue":"12","key":"10.1016\/j.lungcan.2026.109566_b0025","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1158\/2159-8290.CD-20-1863","article-title":"Multiomic Analysis of Lung Tumors Defines Pathways Activated in Neuroendocrine Transformation","volume":"11","author":"Quintanal-Villalonga","year":"2021","journal-title":"Cancer Discov."},{"issue":"19","key":"10.1016\/j.lungcan.2026.109566_b0030","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1111\/1759-7714.14144","article-title":"Comprehensive analysis of treatment modes and clinical outcomes of small cell lung cancer transformed from epidermal growth factor receptor mutant lung adenocarcinoma","volume":"12","author":"Wang","year":"2021","journal-title":"Thorac Cancer."},{"key":"10.1016\/j.lungcan.2026.109566_b0035","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.lungcan.2022.11.016","article-title":"A potential treatment option for transformed small-cell lung cancer on PD-L1 inhibitor-based combination therapy improved survival","volume":"175","author":"Zhang","year":"2023","journal-title":"Lung Cancer."},{"issue":"4","key":"10.1016\/j.lungcan.2026.109566_b0040","first-page":"153","article-title":"Evolution and genotypic characteristics of small cell lung cancer transformation in non-small cell lung carcinomas","volume":"1","author":"Zhong","year":"2021","journal-title":"J Natl Cancer Cent."},{"issue":"4","key":"10.1016\/j.lungcan.2026.109566_b0045","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1200\/JCO.18.01585","article-title":"EGFR-Mutant Adenocarcinomas That Transform to Small-Cell Lung Cancer and Other Neuroendocrine Carcinomas: Clinical Outcomes","volume":"37","author":"Marcoux","year":"2019","journal-title":"J Clin Oncol."},{"issue":"6","key":"10.1016\/j.lungcan.2026.109566_b0050","doi-asserted-by":"crossref","first-page":"6377","DOI":"10.1038\/ncomms7377","article-title":"RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancer","volume":"11","author":"Niederst","year":"2015","journal-title":"Nat Commun."},{"issue":"9","key":"10.1016\/j.lungcan.2026.109566_b0055","article-title":"Detection of EGFR mutations in plasma circulating tumour DNA as a selection criterion for first-line gefitinib treatment in patients with advanced lung adenocarcinoma (BENEFIT): a phase 2, single-arm, multicentre clinical trial. The Lancet","volume":"6","author":"Z w, y c, t a, h g, k w, q z,","year":"2018","journal-title":"Respiratory medicine."},{"key":"10.1016\/j.lungcan.2026.109566_b0060","doi-asserted-by":"crossref","unstructured":"J G, Js L, Sj J, Y C, L O, G K, et al. Comprehensive genomic profiles of small cell lung cancer. Nature. 2015 Jun 8;524(7563). doi:10.1038\/nature14664 PubMed PMID: 26168399.","DOI":"10.1038\/nature14664"},{"issue":"1","key":"10.1016\/j.lungcan.2026.109566_b0065","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12964-023-01260-8","article-title":"Transformation to small cell lung cancer is irrespective of EGFR and accelerated by SMAD4-mediated ASCL1 transcription independently of RB1 in non-small cell lung cancer","volume":"22","author":"Ding","year":"2024","journal-title":"Cell Commun Signal."},{"issue":"12","key":"10.1016\/j.lungcan.2026.109566_b0070","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.6004\/jnccn.2021.0058","article-title":"Small Cell Lung Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology","volume":"19","author":"Ganti","year":"2021","journal-title":"J Natl Compr Canc Netw."},{"key":"10.1016\/j.lungcan.2026.109566_b0075","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ctrv.2017.07.007","article-title":"Outcome of patients with lung adenocarcinoma with transformation to small-cell lung cancer following tyrosine kinase inhibitors treatment: A systematic review and pooled analysis","volume":"59","author":"Roca","year":"2017","journal-title":"Cancer Treat Rev."},{"issue":"1","key":"10.1016\/j.lungcan.2026.109566_b0080","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.lungcan.2012.09.016","article-title":"Clinical modes of EGFR tyrosine kinase inhibitor failure and subsequent management in advanced non-small cell lung cancer","volume":"79","author":"Yang","year":"2013","journal-title":"Lung Cancer."},{"issue":"18","key":"10.1016\/j.lungcan.2026.109566_b0085","doi-asserted-by":"crossref","first-page":"4585","DOI":"10.1158\/1078-0432.CCR-15-3101","article-title":"EGFR Mutations and ALK Rearrangements Are Associated with Low Response Rates to PD-1 Pathway Blockade in Non-Small Cell Lung Cancer: A Retrospective Analysis","volume":"22","author":"Gainor","year":"2016","journal-title":"Clin Cancer Res."},{"issue":"8","key":"10.1016\/j.lungcan.2026.109566_b0090","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1093\/annonc\/mdz167","article-title":"Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry","volume":"30","author":"Mazieres","year":"2019","journal-title":"Ann Oncol."},{"key":"10.1016\/j.lungcan.2026.109566_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2025.108454","article-title":"A randomised non-comparative phase II study of atezolizumab, bevacizumab and chemotherapy in EGFR-mutant NSCLC with acquired resistance - The ETOP 15-19 ABC-lung trial","volume":"202","author":"Soo","year":"2025","journal-title":"Lung Cancer."},{"key":"10.1016\/j.lungcan.2026.109566_b0100","article-title":"Multi-Institution Analysis of Tarlatamab for the Treatment of EGFR-Mutant Transformed Small Cell Lung Cancer","volume":"9","author":"Cooper","year":"2025","journal-title":"JCO Precis Oncol."},{"key":"10.1016\/j.lungcan.2026.109566_b0105","doi-asserted-by":"crossref","unstructured":"M W, Jc Y, Pl M, J F, Dr C, W N, et al. Sunvozertinib, a Selective EGFR Inhibitor for Previously Treated Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations. Cancer discovery. 2022 Jun 7;12(7). doi:10.1158\/2159-8290.CD-21-1615 PubMed PMID: 35404393.","DOI":"10.1158\/2159-8290.CD-21-1615"},{"key":"10.1016\/j.lungcan.2026.109566_b0110","unstructured":"Research C for DE and. FDA grants accelerated approval to sunvozertinib for metastatic non-small cell lung cancer with EGFR exon 20 insertion mutations. FDA [Internet]. 2025 Oct 9 [cited 2026 Jul 12]. Available from: https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-grants-accelerated-approval-sunvozertinib-metastatic-non-small-cell-lung-cancer-egfr-exon-20."},{"key":"10.1016\/j.lungcan.2026.109566_b0115","doi-asserted-by":"crossref","unstructured":"K S, I M, K S, H M, S S, K S, et al. Small cell lung cancer transformation and T790M mutation: complimentary roles in acquired resistance to kinase inhibitors in lung cancer. Scientific reports. 2015 Sep 24;5. doi:10.1038\/srep14447 PubMed PMID: 26400668.","DOI":"10.1038\/srep14447"},{"issue":"5","key":"10.1016\/j.lungcan.2026.109566_b0120","doi-asserted-by":"crossref","first-page":"14447","DOI":"10.1038\/srep14447","article-title":"Small cell lung cancer transformation and T790M mutation: complimentary roles in acquired resistance to kinase inhibitors in lung cancer","volume":"24","author":"Suda","year":"2015","journal-title":"Sci Rep."},{"issue":"26","key":"10.1016\/j.lungcan.2026.109566_b0125","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1200\/JCO.2016.71.9096","article-title":"Clonal History and Genetic Predictors of Transformation Into Small-Cell Carcinomas From Lung Adenocarcinomas","volume":"35","author":"Lee","year":"2017","journal-title":"J Clin Oncol."},{"issue":"8087","key":"10.1016\/j.lungcan.2026.109566_b0130","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1038\/s41586-025-09492-z","article-title":"Neuronal activity-dependent mechanisms of small cell lung cancer pathogenesis","volume":"646","author":"Savchuk","year":"2025","journal-title":"Nature."},{"issue":"5","key":"10.1016\/j.lungcan.2026.109566_b0135","doi-asserted-by":"crossref","first-page":"e1683","DOI":"10.1002\/ctm2.1683","article-title":"Genotyping of RB1 status identifies two distinct subtypes in EGFR-mutant lung cancers with SCLC transformation","volume":"14","author":"Huang","year":"2024","journal-title":"Clin Transl Med."},{"issue":"1","key":"10.1016\/j.lungcan.2026.109566_b0140","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41392-024-01981-3","article-title":"Mechanism exploration and model construction for small cell transformation in EGFR-mutant lung adenocarcinomas","volume":"9","author":"Li","year":"2024","journal-title":"Signal Transduct Target Ther."}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500226006276?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500226006276?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T16:53:07Z","timestamp":1789145587000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500226006276"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":28,"alternative-id":["S0169500226006276"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2026.109566","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genomic Profiling, Risk Stratification, and Post-Transformation Treatment Outcomes in Patients with Transformed Small-Cell Lung Cancer: A Multicenter Analysis","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2026.109566","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"109566"}}